REPL stock news
This page provides real-time market news, earnings updates, and company announcements related to Replimune Group, Inc. (REPL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-05 16:39 EST
Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know
Finviz2026-02-12 15:57:40
Does Replimune Group (REPL) Possess the Opportunity to Surge by 79.61% According to Wall Street Analysts' Predictions?
101 finance2026-03-03 15:57:59
Mirum Finishes Participant Enrollment and Screening for Liver Disease Research
101 finance2026-03-06 14:34:20
XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study
Finviz2026-03-10 16:34:27
JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer
Finviz2026-03-10 16:37:38
Mineralys Shares Climb After FDA Accepts NDA for Blood Pressure Medication
101 finance2026-03-11 16:40:47
COGT Shares Climb After FDA Accepts Bezuclastinib NDA for Non-Advanced SM
101 finance2026-03-17 16:48:55
Replica Cyber’s dual victories affirm its groundbreaking security approach and indicate a surge in adoption momentum
101 finance2026-03-23 16:09:48
Ocugen Shares Drop as Eye Disease Gene Therapy Shows Delays in Phase II Trial
101 finance2026-03-25 17:18:50
CORT Shares Surge After FDA Approval of Lifyorli for Platinum-Resistant Ovarian Cancer
101 finance2026-03-26 17:00:47
RCKT Shares Fall Even After FDA Approves Gene Therapy for Uncommon Disease
101 finance2026-03-30 17:24:58
Replimune’s Bullish Tech Signal vs. Uncertain Biotech Landscape
101 finance2026-04-04 00:09:42
JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer
Finviz2026-03-10 16:37:38
Mineralys Shares Climb After FDA Accepts NDA for Blood Pressure Medication
101 finance2026-03-11 16:40:47
COGT Shares Climb After FDA Accepts Bezuclastinib NDA for Non-Advanced SM
101 finance2026-03-17 16:48:55
Replica Cyber’s dual victories affirm its groundbreaking security approach and indicate a surge in adoption momentum
101 finance2026-03-23 16:09:48
Ocugen Shares Drop as Eye Disease Gene Therapy Shows Delays in Phase II Trial
101 finance2026-03-25 17:18:50
CORT Shares Surge After FDA Approval of Lifyorli for Platinum-Resistant Ovarian Cancer
101 finance2026-03-26 17:00:47
RCKT Shares Fall Even After FDA Approves Gene Therapy for Uncommon Disease
101 finance2026-03-30 17:24:58
Replimune’s Bullish Tech Signal vs. Uncertain Biotech Landscape
101 finance2026-04-04 00:09:42
REPL stock chart
REPL stock detailsREPL stock price change
On the last trading day, REPL stock closed at 8.41 USD, with a price change of 10.51% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more